In the last 12 months, insiders at TriSalus Life Sciences, Inc. ($TLSI) filed 138 transactions with the SEC: 22 open-market purchases totaling $2,628,259 and 21 sales totaling $375,116. Net insider sentiment: net buying.
TriSalus Life Sciences, Inc. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Stansky Michael P (Director) — 3 transactions totaling $1,480,502
- Frankenius Equity AB (Not found) — 2 transactions totaling $249,999
- Murphy Sean (Director) — 2 transactions totaling $232,499
- Young James Emmett (Chief Financial Officer) — 6 transactions totaling $231,747
- Stevens Jennifer (Chief Regulatory Officer) — 7 transactions totaling $206,993
View all SEC Filings for TriSalus Life Sciences, Inc. (TLSI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| July 31, 2025 | MATLIN DAVID J | Director | C | Series A Preferred Stock | 100000 | $0.00 | 0.0000 | 32,272,462 | 100.00% | 0.31% |
| July 31, 2025 | MATLIN DAVID J | Director | C | Common Stock | 330000 | $0.00 | 1,271,944.0000 | 32,272,462 | 35.03% | 1.02% |
| March 11, 2026 | Marshak Richard | Chief Commercial Officer | S | Common Stock | 1449 | $4.13 | 112,405.0000 | 49,964,311 | 1.27% | 0.00% |
| March 16, 2026 | Cox Bryan F. | Chief of Research | S | Common Stock | 579 | $4.12 | 163,415.0000 | 49,964,311 | 0.35% | 0.00% |
| March 12, 2026 | Cox Bryan F. | Chief of Research | S | Common Stock | 1467 | $4.09 | 163,994.0000 | 49,964,311 | 0.89% | 0.00% |
| March 11, 2026 | Cox Bryan F. | Chief of Research | S | Common Stock | 1138 | $4.13 | 165,461.0000 | 49,964,311 | 0.68% | 0.00% |
| March 16, 2026 | Devlin Jodi | Chief of Clinical Operations | S | Common Stock | 273 | $4.12 | 97,364.0000 | 49,964,311 | 0.28% | 0.00% |
| March 16, 2026 | Marshak Richard | Chief Commercial Officer | S | Common Stock | 419 | $4.12 | 110,397.0000 | 49,964,311 | 0.38% | 0.00% |
| March 11, 2026 | Devlin Jodi | Chief of Clinical Operations | S | Common Stock | 1162 | $4.13 | 99,409.0000 | 49,964,311 | 1.16% | 0.00% |
| March 12, 2026 | Stevens Jennifer | Chief Regulatory Officer | S | Common Stock | 1552 | $4.09 | 124,884.0000 | 49,964,311 | 1.23% | 0.00% |
| March 16, 2026 | Stevens Jennifer | Chief Regulatory Officer | S | Common Stock | 774 | $4.12 | 124,110.0000 | 49,964,311 | 0.62% | 0.00% |
| March 11, 2026 | Szela Mary T | CEO and President | S | Common Stock | 4358 | $4.13 | 768,931.0000 | 49,964,311 | 0.56% | 0.01% |
| March 17, 2026 | Szela Mary T | CEO and President | S | Common Stock | 15944 | $3.85 | 752,987.0000 | 49,964,311 | 2.07% | 0.03% |
| March 11, 2026 | Stevens Jennifer | Chief Regulatory Officer | S | Common Stock | 1204 | $4.13 | 126,436.0000 | 49,964,311 | 0.94% | 0.00% |
| March 12, 2026 | Devlin Jodi | Chief of Clinical Operations | S | Common Stock | 1772 | $4.09 | 97,637.0000 | 49,964,311 | 1.78% | 0.00% |
| March 12, 2026 | Marshak Richard | Chief Commercial Officer | S | Common Stock | 1589 | $4.09 | 110,816.0000 | 49,964,311 | 1.41% | 0.00% |
| Feb. 23, 2026 | Stansky Michael P | Director | P | Common Stock | 243900 | $4.10 | 986,830.0000 | 49,964,311 | 32.83% | 0.49% |
| Feb. 23, 2026 | Patience David | Chief Financial Officer | P | Common Stock | 3657 | $4.10 | 268,657.0000 | 49,964,311 | 1.38% | 0.01% |
| Feb. 23, 2026 | Gordon Gary B. | Director | P | Common Stock | 9756 | $4.10 | 9,756.0000 | 49,964,311 | 9999.99% | 0.02% |
| Feb. 23, 2026 | Valle William | Director | P | Common Stock | 30487 | $4.10 | 30,487.0000 | 49,964,311 | 9999.99% | 0.06% |
| Feb. 23, 2026 | Szela Mary T | CEO and President | P | Common Stock | 30487 | $4.10 | 773,289.0000 | 49,964,311 | 4.10% | 0.06% |
| Feb. 23, 2026 | Stansky Michael P | Director | P | Common Stock | 117198 | $4.10 | 986,830.0000 | 49,964,311 | 13.48% | 0.23% |
| Feb. 4, 2026 | Stansky Michael P | Director | A | Director Stock Option (right to buy) | 92537 | $0.00 | 92,537.0000 | 49,964,311 | 9999.99% | 0.19% |
| Nov. 24, 2025 | Devlin Jodi | Chief of Clinical Operations | A | Common Stock | 50000 | $0.00 | 100,571.0000 | 49,964,311 | 98.87% | 0.10% |
| Nov. 24, 2025 | Marshak Richard | Chief Commercial Officer | A | Common Stock | 60000 | $0.00 | 113,854.0000 | 49,964,311 | 111.41% | 0.12% |
| Nov. 24, 2025 | Stevens Jennifer | Chief Regulatory Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 323,782.0000 | 49,964,311 | 44.69% | 0.20% |
| Nov. 24, 2025 | Stevens Jennifer | Chief Regulatory Officer | A | Common Stock | 50000 | $0.00 | 127,640.0000 | 49,964,311 | 64.40% | 0.10% |
| Nov. 24, 2025 | Szela Mary T | CEO and President | A | Employee Stock Option (right to buy) | 250000 | $0.00 | 1,578,182.0000 | 49,964,311 | 18.82% | 0.50% |
| Nov. 24, 2025 | Szela Mary T | CEO and President | A | Common Stock | 300000 | $0.00 | 742,802.0000 | 49,964,311 | 67.75% | 0.60% |
| Nov. 24, 2025 | Szela Mary T | CEO and President | A | Common Stock | 125000 | $0.00 | 442,802.0000 | 49,964,311 | 39.33% | 0.25% |
| Feb. 13, 2024 | Szela Mary T | CEO and President | A | Common Stock | 125000 | $0.00 | 317,802.0000 | 0 | 64.83% | 0.00% |
| Nov. 24, 2025 | Cox Bryan F. | Chief of Research | A | Employee Stock Option (right to buy) | 80000 | $0.00 | 261,954.0000 | 49,964,311 | 43.97% | 0.16% |
| Nov. 24, 2025 | Cox Bryan F. | Chief of Research | A | Common Stock | 40000 | $0.00 | 166,599.0000 | 49,964,311 | 31.60% | 0.08% |
| Nov. 24, 2025 | Devlin Jodi | Chief of Clinical Operations | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 463,750.0000 | 49,964,311 | 27.49% | 0.20% |
| Nov. 24, 2025 | Patience David | Chief Financial Officer | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 668,899.0000 | 49,964,311 | 24.12% | 0.26% |
| Nov. 24, 2025 | Patience David | Chief Financial Officer | A | Common Stock | 65000 | $0.00 | 265,000.0000 | 49,964,311 | 32.50% | 0.13% |
| Nov. 24, 2025 | Marshak Richard | Chief Commercial Officer | A | Employee Stock Option (right to buy) | 120000 | $0.00 | 408,937.0000 | 49,964,311 | 41.53% | 0.24% |
| Aug. 28, 2025 | Patience David | Chief Financial Officer | A | Employee Stock Option (right to buy) | 248899 | $0.00 | 538,899.0000 | 32,272,462 | 85.83% | 0.77% |
| Aug. 14, 2025 | Patience David | Chief Financial Officer | A | Common Stock | 200000 | $0.00 | 200,000.0000 | 32,272,462 | 9999.99% | 0.62% |
| Aug. 14, 2025 | Patience David | Chief Financial Officer | A | Employee Stock Option (right to buy) | 290000 | $0.00 | 290,000.0000 | 32,272,462 | 9999.99% | 0.90% |
| June 12, 2025 | Desai Arjun JJ | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 65,000.0000 | 32,272,462 | 30.00% | 0.05% |
| June 12, 2025 | Murphy Sean | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 554,681.0000 | 32,272,462 | 2.78% | 0.05% |
| June 12, 2025 | MATLIN DAVID J | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 65,000.0000 | 32,272,462 | 30.00% | 0.05% |
| June 12, 2025 | HICKS KERRY R | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 89,222.0000 | 32,272,462 | 20.21% | 0.05% |
| June 12, 2025 | Gordon Gary B. | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 56,250.0000 | 32,272,462 | 36.36% | 0.05% |
| June 12, 2025 | Wahlstrom Mats | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 200,945.0000 | 32,272,462 | 8.07% | 0.05% |
| June 12, 2025 | Valle William | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 56,250.0000 | 32,272,462 | 36.36% | 0.05% |
| May 19, 2025 | Stevens Jennifer | Chief Regulatory Officer | A | Common Stock | 28455 | $5.18 | 86,344.0000 | 32,272,462 | 49.15% | 0.09% |
| May 19, 2025 | Young James Emmett | Chief Financial Officer | A | Common Stock | 13175 | $5.18 | 79,663.0000 | 32,272,462 | 19.82% | 0.04% |
| May 19, 2025 | Cox Bryan F. | Chief of Research | A | Common Stock | 15722 | $5.18 | 124,179.0000 | 32,272,462 | 14.50% | 0.05% |
| May 19, 2025 | Cox Bryan F. | Chief of Research | S | Common Stock | 4764 | $5.18 | 119,415.0000 | 32,272,462 | 3.84% | 0.01% |
| May 19, 2025 | Devlin Jodi | Chief of Clinical Operations | A | Common Stock | 24131 | $5.18 | 57,528.0000 | 32,272,462 | 72.25% | 0.07% |
| May 19, 2025 | Devlin Jodi | Chief of Clinical Operations | S | Common Stock | 4764 | $5.18 | 52,764.0000 | 32,272,462 | 8.28% | 0.01% |
| May 19, 2025 | Marshak Richard | Chief Commercial Officer | A | Common Stock | 21428 | $5.18 | 75,698.0000 | 32,272,462 | 39.48% | 0.07% |
| May 19, 2025 | Marshak Richard | Chief Commercial Officer | S | Common Stock | 6597 | $5.18 | 69,101.0000 | 32,272,462 | 8.71% | 0.02% |
| May 19, 2025 | Murphy Sean | Director | A | Common Stock | 44884 | $5.18 | 679,256.0000 | 32,272,462 | 7.08% | 0.14% |
| May 19, 2025 | Stevens Jennifer | Chief Regulatory Officer | S | Common Stock | 8704 | $5.18 | 77,640.0000 | 32,272,462 | 10.08% | 0.03% |
| Feb. 18, 2025 | Szela Mary T | CEO AND PRESIDENT | A | Common Stock | 21089 | $0.00 | 465,348.0000 | 0 | 4.75% | 0.00% |
| Feb. 18, 2025 | Devlin Jodi | Chief of Clinical Operations | A | Common Stock | 5272 | $0.00 | 33,397.0000 | 0 | 18.74% | 0.00% |
| Feb. 18, 2025 | Murphy Sean | Chief Manuf, Strategy&Bus Dev. | A | Common Stock | 15817 | $0.00 | 634,372.0000 | 0 | 2.56% | 0.00% |
| Feb. 18, 2025 | Young James Emmett | Chief Financial Officer | A | Common Stock | 14762 | $0.00 | 66,488.0000 | 0 | 28.54% | 0.00% |
| Feb. 18, 2025 | Stevens Jennifer | CHIEF REGULATORY OFFICER | A | Common Stock | 14481 | $0.00 | 57,889.0000 | 0 | 33.36% | 0.00% |
| Feb. 18, 2025 | Cox Bryan F. | CHIEF OF RESEARCH | A | Common Stock | 11450 | $0.00 | 108,457.0000 | 0 | 11.80% | 0.00% |
| Feb. 18, 2025 | Marshak Richard | Chief Commercial Officer | A | Common Stock | 7644 | $0.00 | 54,270.0000 | 0 | 16.39% | 0.00% |
| Feb. 10, 2025 | Frankenius Equity AB | Not found | J | Series A Convertible Preferred Stock | 205853 | $0.00 | 435,853.0000 | 0 | 89.50% | 0.00% |
| Feb. 10, 2025 | Wahlstrom Mats | Not found | J | Series A Convertible Preferred Stock | 44750 | $0.00 | 94,750.0000 | 0 | 89.50% | 0.00% |
| Feb. 10, 2025 | MATLIN DAVID J | Not found | J | Series A Preferred Stock | 89501 | $0.00 | 189,501.0000 | 0 | 89.50% | 0.00% |
| Feb. 5, 2025 | Young James Emmett | Chief Financial Officer | P | Common Stock | 6000 | $5.65 | 51,726.0000 | 0 | 13.12% | 0.00% |
| Jan. 29, 2025 | Valle William | Not found | A | Director Stock Option (right to buy) | 6250 | $0.00 | 6,250.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2025 | Gordon Gary B. | Not found | A | Director Stock Option (right to buy) | 6250 | $0.00 | 6,250.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2025 | Valle William | Not found | A | Director Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2025 | Gordon Gary B. | Not found | A | Director Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2025 | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 5010 | $5.28 | 444,259.0000 | 0 | 1.14% | 0.00% |
| Jan. 29, 2025 | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 5030 | $5.03 | 439,249.0000 | 0 | 1.16% | 0.00% |
| Jan. 27, 2025 | Stevens Jennifer | CHIEF REGULATORY OFFICER | A | Common Stock | 10625 | $0.00 | 43,408.0000 | 0 | 32.41% | 0.00% |
| Jan. 27, 2025 | Marshak Richard | Chief Commercial Officer | A | Common Stock | 12500 | $0.00 | 46,626.0000 | 0 | 36.63% | 0.00% |
| Jan. 27, 2025 | Devlin Jodi | Chief of COMMERC. OPERATIONS | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Murphy Sean | Chief Manuf, Strategy&Bus Dev. | P | Common Stock | 15000 | $5.31 | 603,555.0000 | 0 | 2.55% | 0.00% |
| Jan. 28, 2025 | Murphy Sean | Chief Manuf, Strategy&Bus Dev. | P | Common Stock | 15000 | $5.17 | 618,555.0000 | 0 | 2.49% | 0.00% |
| Jan. 27, 2025 | Murphy Sean | Chief Manuf, Strategy&Bus Dev. | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Cox Bryan F. | CHIEF OF RESEARCH | A | Common Stock | 10625 | $0.00 | 97,007.0000 | 0 | 12.30% | 0.00% |
| Jan. 27, 2025 | Cox Bryan F. | CHIEF OF RESEARCH | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Young James Emmett | Chief Financial Officer | A | Common Stock | 12500 | $0.00 | 45,726.0000 | 0 | 37.62% | 0.00% |
| Jan. 27, 2025 | Young James Emmett | Chief Financial Officer | P | Common Stock | 24000 | $5.40 | 45,726.0000 | 0 | 110.47% | 0.00% |
| Jan. 27, 2025 | Young James Emmett | Chief Financial Officer | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Devlin Jodi | Chief of COMMERC. OPERATIONS | A | Common Stock | 10625 | $0.00 | 28,125.0000 | 0 | 60.71% | 0.00% |
| Jan. 27, 2025 | Stevens Jennifer | CHIEF REGULATORY OFFICER | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Marshak Richard | Chief Commercial Officer | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Szela Mary T | CEO AND PRESIDENT | A | Common Stock | 40000 | $0.00 | 424,677.0000 | 0 | 10.40% | 0.00% |
| Jan. 27, 2025 | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 4826 | $5.42 | 429,503.0000 | 0 | 1.14% | 0.00% |
| Jan. 28, 2025 | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 4716 | $5.12 | 434,219.0000 | 0 | 1.10% | 0.00% |
| Jan. 27, 2025 | Szela Mary T | CEO AND PRESIDENT | A | Employee Stock Option (right to buy) | 240000 | $0.00 | 240,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Murphy Sean | Chief Manuf, Strategy&Bus Dev. | A | Common Stock | 12500 | $0.00 | 618,555.0000 | 0 | 2.06% | 0.00% |
| Jan. 2, 2025 | MATLIN DAVID J | Not found | A | Common Stock | 10040 | $0.00 | 941,944.0000 | 0 | 1.08% | 0.00% |
| Jan. 2, 2025 | Hyveled Liselotte | Not found | A | Common Stock | 10040 | $0.00 | 10,040.0000 | 0 | 9999.99% | 0.00% |
| Dec. 17, 2024 | Wahlstrom Mats | Not found | A | Common Stock | 25188 | $3.97 | 2,665,202.0000 | 0 | 0.95% | 0.00% |
| Dec. 17, 2024 | Frankenius Equity AB | Not found | P | Common Stock | 62972 | $3.97 | 6,230,748.0000 | 0 | 1.02% | 0.00% |
| Oct. 5, 2024 | Cox Bryan F. | CHIEF SCIENTIFIC & MANUFACT. | S | Common Stock | 314 | $4.44 | 86,382.0000 | 0 | 0.36% | 0.00% |
| Dec. 10, 2024 | Desai Arjun JJ | Not found | S | Common Stock | 30000 | $3.69 | 247,127.0000 | 0 | 10.83% | 0.00% |
| Nov. 22, 2024 | Wahlstrom Mats | Not found | P | Common Stock | 5000 | $4.55 | 2,640,014.0000 | 0 | 0.19% | 0.00% |
| Nov. 21, 2024 | Wahlstrom Mats | Not found | P | Common Stock | 8687 | $4.44 | 2,635,014.0000 | 0 | 0.33% | 0.00% |
| Nov. 20, 2024 | Wahlstrom Mats | Not found | P | Common Stock | 2040 | $4.16 | 2,626,327.0000 | 0 | 0.08% | 0.00% |
| Nov. 14, 2024 | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Common Stock | 6875 | $0.00 | 34,126.0000 | 0 | 25.23% | 0.00% |
| Nov. 14, 2024 | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Employee Stock Option (right to buy) | 41250 | $0.00 | 41,250.0000 | 0 | 9999.99% | 0.00% |
| Sept. 13, 2024 | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 1295 | $4.83 | 378,677.0000 | 0 | 0.34% | 0.00% |
| Sept. 12, 2024 | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 7520 | $5.20 | 377,382.0000 | 0 | 2.03% | 0.00% |
| Sept. 13, 2024 | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 6000 | $5.00 | 384,677.0000 | 0 | 1.58% | 0.00% |
| Sept. 10, 2024 | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 5000 | $4.97 | 369,862.0000 | 0 | 1.37% | 0.00% |
| Aug. 28, 2024 | Martin George Kelly | Not found | S | Common Stock | 9 | $5.50 | 247,176.0000 | 0 | 0.00% | 0.00% |
| Aug. 13, 2024 | HICKS KERRY R | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Wahlstrom Mats | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Martin George Kelly | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Hyveled Liselotte | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | VON ESCHENBACH ANDREW C. | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Singhal Anil K. | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Desai Arjun JJ | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | MATLIN DAVID J | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | Desai Arjun JJ | Not found | D | Redeemable Warrants | 246667 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 1, 2024 | Desai Arjun JJ | Not found | A | Common Stock | 74000 | $0.00 | 277,127.0000 | 0 | 36.43% | 0.00% |
| June 3, 2024 | VON ESCHENBACH ANDREW C. | Not found | G | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | VON ESCHENBACH ANDREW C. | Not found | G | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 50.00% | 0.00% |
| May 6, 2024 | Hyveled Liselotte | Not found | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2024 | Szela Mary T | CEO AND PRESIDENT | A | Common Stock | 84899 | $0.00 | 364,862.0000 | 0 | 30.33% | 0.00% |
| Feb. 12, 2024 | Katz Steven C | CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Katz Steven C | CHIEF MEDICAL OFFICER | A | Common Stock | 34144 | $0.00 | 68,587.0000 | 0 | 99.13% | 0.00% |
| Feb. 12, 2024 | Murphy Sean | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Murphy Sean | CHIEF FINANCIAL OFFICER | A | Common Stock | 34144 | $0.00 | 576,055.0000 | 0 | 6.30% | 0.00% |
| Feb. 12, 2024 | Devlin Jodi | PRESIDENT, COMMERC. OPERATIONS | A | Employee Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Devlin Jodi | PRESIDENT, COMMERC. OPERATIONS | A | Common Stock | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Stevens Jennifer | CHIEF REGULATORY OFFICER | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Stevens Jennifer | CHIEF REGULATORY OFFICER | A | Common Stock | 14752 | $0.00 | 32,783.0000 | 0 | 81.81% | 0.00% |
| Feb. 12, 2024 | Cox Bryan F. | CHIEF SCIENTIFIC & MANUFACT. | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Cox Bryan F. | CHIEF SCIENTIFIC & MANUFACT. | A | Common Stock | 14752 | $0.00 | 86,696.0000 | 0 | 20.50% | 0.00% |
| Feb. 12, 2024 | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Common Stock | 14752 | $0.00 | 27,251.0000 | 0 | 118.03% | 0.00% |
| Feb. 13, 2024 | Szela Mary T | CEO AND PRESIDENT | A | Employee Stock Option (right to buy) | 288750 | $0.00 | 288,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | A | Employee Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | Murphy Sean | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |